Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b840490ce4e7830aa852a942094b9df0 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1157 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1358 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-24 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0645 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0786 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0775 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate |
2020-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1a20500eb3ebf4f417a7663472aa073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02f0967b52eea67b7927b714989a2792 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4baa82a2a8f1cde2c3f6669edbfa1267 |
publicationDate |
2020-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2020184425-A1 |
titleOfInvention |
Method for inducing macrophages, inducer for anti-inflammatory macrophages and pharmaceutical composition |
abstract |
This method for inducing macrophages involves culturing macrophages in the presence of exosomes produced from interferon γ-added mesenchymal stem cells, and inducing anti-inflammatory macrophages. This inducer for anti-inflammatory macrophages contains exosomes produced from interferon γ-added mesenchymal stem cells as an effective ingredient. This pharmaceutical composition comprises said inducer. |
priorityDate |
2019-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |